Gene description for RSL1D1 |
Gene name |
ribosomal L1 domain containing 1 |
Gene symbol |
RSL1D1 |
Other names/aliases |
CSIG L12 PBK1 UTP30 |
Species |
Homo sapiens |
Experiment description of studies that identified RSL1D1 in Prostate cancer cells |
1
|
Experiment ID | 851 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS - Rep 1 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
2
|
Experiment ID | 852 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS - Rep 2 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
3
|
Experiment ID | 853 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS - Rep 3 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
4
|
Experiment ID | 1195 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer. |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget.
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP, EtOH |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|